Mayo Clinic is for the benefit of patients worldwide while generating revenue to support clinical practic.
Business Model:
Revenue: $14B
Employees: 10,001-999,999
Address: 200 First St. SW,
City: Rochester
State: MN
Zip: 55905
Country: US
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicated efforts bring significant financial support to Mayo&s;s patient care, education and research efforts.
Contact Phone:
+15072842511
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2021 | Tympany Medical | Seed Round | 0 |
8/2021 | JOGO Health | Seed Round | 0 |
10/2019 | Atrian Medical | Seed Round | 2.6M |
1/2015 | Stride Health | Seed Round | 2.4M |
8/2017 | UNITY Biotechnology | Series B | 35M |
7/2016 | Torax Medical | Series E | 0 |
11/2017 | Progentec Diagnostics | Venture Round | 1.3M |
1/2022 | The Patient Company | Convertible Note | 1M |
5/2007 | Naviscan | Series C | 15M |
6/2021 | Helix | Series C | 50M |
7/2017 | Evelo Biosciences | Series B | 50M |
4/2009 | Torax Medical | Series C | 15M |
6/2005 | Torax Medical | Series B | 10M |
2/2015 | Lifecode | Series A | 0 |
3/2021 | TripleBlind | Seed Round | 0 |
12/2020 | nference | Series C | 0 |
6/2021 | R-Zero | Series B | 50M |
6/2017 | Vineti | Series A | 13.8M |
12/2019 | Hui-Gene Therapeutics | Series A | 14.2M |
9/2012 | Torax Medical | Series D | 0 |
1/2016 | Epirium Bio | Venture Round | 192k |
7/2018 | Marigold Health | Pre Seed Round | - |
8/2019 | Qlaris Bio | Series A | 8.2M |
1/2020 | nference | Series B | 0 |
4/2018 | Geneticure | Seed Round | 1.4M |
1/2020 | Progentec Diagnostics | Series A | 5M |
12/2022 | Turtle Health | Seed Round | 0 |
5/2021 | Anumana | Series B | 60M |
10/2019 | Cadence Neuroscience | Series A | 15M |
8/2007 | Kardia Health Systems | Venture Round | 3.3M |
4/2018 | Vineti | Series B | 33.5M |
12/2019 | Elysium | Series C | 40M |
1/2020 | Novome Biotechnologies | Series A | 0 |
2/2021 | Anumana | Series A | 25.7M |
11/2005 | Naviscan | Series B | 6.5M |
11/2021 | Tympany Medical | Seed Round | 0 |
6/2021 | R-Zero | Series B | 0 |
6/2021 | Helix | Series C | 0 |
3/2021 | TripleBlind | Seed Round | 0 |
12/2020 | nference | Series C | 0 |
1/2020 | Progentec Diagnostics | Series A | 0 |
1/2020 | nference | Series B | 0 |
1/2020 | Novome Biotechnologies | Series A | 0 |
12/2019 | Elysium | Series C | 0 |
12/2019 | Hui-Gene Therapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|